NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.

Cancer incidence rises sharply with age, yet the biological mechanisms that make older patients more vulnerable to treatment failure remain poorly ...

Induced pluripotent stem cells (iPSCs) are derived from adult cells, such as skin or blood cells, which have been “reprogrammed” back to a stem-cell-like state. This transformation grants them the ...

SYDNEY, Australia, April 13, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment ...

The field of plant epigenetics is increasingly recognized for its crucial role in mediating plant responses to diverse environmental stressors intensified ...

Why does the same virus barely faze one person while sending another to the hospital? New research shows the answer lies in a molecular record etched into our immune cells by both our genes and our ...

SEATTLE, April 07, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leader in advanced induced pluripotent stem cell (iPSC)-based solutions, today announced expansion of its intellectual property portfolio with ...

The MarketWatch News Department was not involved in the creation of this content. SEATTLE, April 07, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leader in advanced induced pluripotent stem cell (iPSC)-based ...

Yuancheng Ryan Lu could barely breathe while he waited for his labmate to adjust the microscope focus. On the slide in front of them were the results of Lu’s latest attempt to turn back time for ...